In support of this, many in vivo studies that utilise antibody treatment have also shown marked reduction of metastatic potential in cancer cells following the inhibition of GPIbα and GPIIb/IIIa receptor sites and VWF [72, 80, 82, 83]. Here, VWF is linked to cancer.